Estrella Immunopharma, Inc.ESLANASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank25
3Y CAGR-31.7%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-31.7%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$3.18M+1.2%
2024$3.14M-29.5%
2023$4.45M-55.4%
2022$9.99M+102.9%
2021$4.92M-